AbbVie Inc. (ABBV) Balance Sheet
ABBV balance sheet, 2025
December 31, 2025 · U.S. dollars$133.96B assets = $137.19B liabilities + −$3.23B equity
Liabilities exceed assets: shareholders’ equity is negative (−$3.23B).
Both columns are drawn to the same scale: what ABBV owns equals what it owes plus shareholders’ equity. Hover a block for its value.
ABBV financial health
Descriptive bands, not a rating. Fiscal 2025.
ABBV balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $66.10B2016 | $133.96B2025 | +8.2%/yr | |
| Total liabilities | $61.46B2016 | $137.19B2025 | +9.3%/yr | |
| Shareholders’ equity | $4.64B2016 | −$3.23B2025 | — | |
| Cash & short-term investments | $6.42B2016 | $5.26B2025 | −2.2%/yr | |
| Total debt | $36.84B2016 | $69.07B2025 | +7.2%/yr | |
| Net cash (debt) | −$30.42B2016 | −$63.81B2025 | −$33.4B | |
| Working capital | $6.41B2016 | −$14.23B2025 | −$20.6B | |
| Book value per share | $2.842016 | −$1.822025 | — | |
| Current ratio | 1.652016 | 0.672025 | −0.98 | |
| Debt / equity | 7.952016 | 20.172024 | +12.22 | |
| Shares outstanding | 1.63B2016 | 1.77B2025 | +0.9%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
ABBV assets
ABBV liabilities and equity
ABBV debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
ABBV balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $5.26B | $5.55B | $12.82B | $9.23B | $9.83B | $8.48B | $39.92B | $8.06B | $9.79B | $6.42B |
| Cash & equivalents | $5.23B | $5.52B | $12.81B | $9.20B | $9.75B | $8.45B | $39.92B | $7.29B | $9.30B | $5.10B |
| Short-term investments | $28.0M | $31.0M | $2.0M | $28.0M | $84.0M | $30.0M | $0 | $772.0M | $486.0M | $1.32B |
| Receivables | $12.59B | $10.92B | $11.15B | $11.25B | $9.98B | $8.82B | $5.43B | $5.38B | $5.09B | $4.76B |
| Inventory | $4.95B | $4.18B | $4.10B | $3.58B | $3.13B | $3.31B | $1.81B | $1.60B | $1.60B | $1.44B |
| Other current assets | $6.26B | $4.93B | $4.93B | $4.40B | $4.99B | $3.56B | $2.35B | $1.90B | $4.74B | $3.56B |
| Total current assets | $29.06B | $25.58B | $33.00B | $28.46B | $27.93B | $24.17B | $49.52B | $16.95B | $21.22B | $16.19B |
| Property, plant & equipment (net) | $6.37B | $5.13B | $4.99B | $4.93B | $5.11B | $5.25B | $2.96B | $2.88B | $2.80B | $2.60B |
| Goodwill & intangible assets | $88.28B | $95.02B | $87.90B | $99.59B | $108.33B | $116.00B | $34.25B | $36.90B | $43.34B | $44.31B |
| Long-term investments | $268.0M | $279.0M | $304.0M | $241.0M | $277.0M | $293.0M | $93.0M | $1.42B | $2.09B | $1.78B |
| Other non-current assets | $9.98B | $9.14B | $8.51B | $5.57B | $4.88B | $4.85B | $2.29B | $1.21B | $1.33B | $1.21B |
| Total assets | $133.96B | $135.16B | $134.71B | $138.81B | $146.53B | $150.56B | $89.11B | $59.35B | $70.79B | $66.10B |
| Liabilities | ||||||||||
| Accounts payable | $3.59B | $2.94B | $3.69B | $2.93B | $2.88B | $2.28B | $1.45B | $1.55B | $1.47B | $1.41B |
| Short-term debt | $8.75B | $6.80B | $7.19B | $4.30B | $12.67B | $8.68B | $3.75B | $5.31B | $6.42B | $402.0M |
| Deferred revenue | — | — | −$3.69B | — | — | — | — | — | — | — |
| Total current liabilities | $43.29B | $38.75B | $37.84B | $29.54B | $35.19B | $28.66B | $15.59B | $17.24B | $16.64B | $9.78B |
| Long-term debt | $58.94B | $60.34B | $52.19B | $59.13B | $64.19B | $77.55B | $62.98B | $35.00B | $30.95B | $36.44B |
| Other long-term liabilities | $34.96B | $32.71B | $34.28B | $32.84B | $31.71B | $31.25B | $18.73B | $15.56B | $18.09B | $15.24B |
| Total liabilities | $137.19B | $131.80B | $124.31B | $121.52B | $131.09B | $137.47B | $97.29B | $67.80B | $65.69B | $61.46B |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $18.0M | $18.0M | $20.20B | $19.26B | $18.32B | $17.40B | $15.21B | $14.77B | $14.29B | $13.70B |
| Retained earnings (deficit) | −$15.49B | −$7.90B | −$1.00B | $4.78B | $3.13B | $1.05B | $4.72B | $3.37B | $5.46B | $4.38B |
| Treasury stock | — | — | −$6.53B | −$4.59B | −$3.14B | −$2.26B | −$24.50B | −$24.11B | −$11.92B | −$10.85B |
| Accumulated other comprehensive income | −$1.14B | −$1.93B | −$2.31B | −$2.20B | −$2.90B | −$3.12B | −$3.60B | −$2.48B | −$2.73B | −$2.59B |
| Minority interest | $42.0M | $39.0M | $37.0M | $33.0M | $28.0M | $21.0M | $0 | $0 | $0 | $0 |
| Total shareholders' equity | −$3.23B | $3.36B | $10.40B | $17.29B | $15.44B | $13.10B | −$8.17B | −$8.45B | $5.10B | $4.64B |
| Key figures | ||||||||||
| Total debt | $69.07B | $67.84B | $60.12B | $64.19B | $77.58B | $87.06B | $67.09B | $40.31B | $37.37B | $36.84B |
| Net cash (debt) | −$63.81B | −$62.29B | −$47.30B | −$54.96B | −$67.75B | −$78.58B | −$27.16B | −$32.25B | −$27.58B | −$30.42B |
| Working capital | −$14.23B | −$13.17B | −$4.84B | −$1.07B | −$7.27B | −$4.49B | $33.93B | −$294.0M | $4.58B | $6.41B |
| Tangible book value | −$91.51B | −$91.66B | −$77.51B | −$82.31B | −$92.89B | −$102.90B | −$42.42B | −$45.34B | −$38.25B | −$39.68B |
| Book value per share | −$1.82 | $1.90 | $5.86 | $9.72 | $8.69 | $7.83 | −$5.51 | −$5.46 | $3.18 | $2.84 |
| Shares outstanding | 1.77B | 1.77B | 1.77B | 1.78B | 1.78B | 1.67B | 1.48B | 1.55B | 1.60B | 1.63B |
| Current ratio | 0.67 | 0.66 | 0.87 | 0.96 | 0.79 | 0.84 | 3.18 | 0.98 | 1.28 | 1.65 |
| Quick ratio | 0.41 | 0.43 | 0.63 | 0.69 | 0.56 | 0.60 | 2.91 | 0.78 | 0.89 | 1.14 |
| Debt / equity | — | 20.17 | 5.78 | 3.71 | 5.03 | 6.65 | — | — | 7.33 | 7.95 |
| Equity / assets | −2.4% | 2.5% | 7.7% | 12.5% | 10.5% | 8.7% | −9.2% | −14.2% | 7.2% | 7.0% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $6.57B | $9.39B | $5.26B | $5.67B | $6.47B | $5.18B | $5.55B | $7.29B | $13.16B | $18.07B | $12.82B | $13.29B |
| Cash & equivalents | $6.57B | $9.39B | $5.23B | $5.63B | $6.47B | $5.17B | $5.52B | $7.26B | $13.13B | $18.07B | $12.81B | $13.29B |
| Short-term investments | — | — | $28.0M | $42.0M | $0 | $1.0M | $31.0M | $28.0M | $27.0M | $2.0M | $2.0M | $3.0M |
| Receivables | $13.82B | $12.48B | $12.59B | $12.77B | $12.64B | $12.48B | $10.92B | $11.47B | $11.72B | $11.95B | $11.15B | $11.41B |
| Inventory | $5.13B | $5.05B | $4.95B | $4.94B | $4.96B | $4.53B | $4.18B | $4.45B | $4.22B | $4.25B | $4.10B | $3.98B |
| Other current assets | $8.15B | $6.61B | $6.26B | $5.16B | $5.20B | $5.50B | $4.93B | $4.58B | $4.72B | $4.61B | $4.93B | $4.54B |
| Total current assets | $33.67B | $33.53B | $29.06B | $28.54B | $29.26B | $27.68B | $25.58B | $27.79B | $33.82B | $38.87B | $33.00B | $33.22B |
| Property, plant & equipment (net) | $5.80B | $5.69B | $6.37B | $5.48B | $5.28B | $5.24B | $5.13B | $5.14B | $5.02B | $4.98B | $4.99B | $4.93B |
| Goodwill & intangible assets | $84.66B | $86.44B | $88.28B | $89.94B | $92.67B | $93.77B | $95.02B | $101.94B | $93.63B | $95.65B | $87.90B | $90.69B |
| Long-term investments | $266.0M | $268.0M | $268.0M | $291.0M | $310.0M | $287.0M | $279.0M | $267.0M | $272.0M | $305.0M | $304.0M | $275.0M |
| Other non-current assets | $10.74B | $10.54B | $9.98B | $9.64B | $9.66B | $9.19B | $9.14B | $8.29B | $9.20B | $9.07B | $8.51B | $7.09B |
| Total assets | $135.13B | $136.46B | $133.96B | $133.90B | $137.18B | $136.16B | $135.16B | $143.42B | $141.94B | $148.87B | $134.71B | $136.22B |
| Liabilities | ||||||||||||
| Accounts payable | $33.17B | $33.61B | $34.42B | $33.36B | $31.83B | $30.96B | $31.91B | $30.40B | $29.30B | $31.26B | $3.69B | $29.57B |
| Short-term debt | $8.34B | $8.33B | $8.55B | $5.77B | $7.52B | $5.36B | $6.80B | $12.57B | $12.59B | $10.20B | $7.19B | $5.12B |
| Deferred revenue | — | — | — | — | — | — | — | −$30.40B | — | — | — | −$29.57B |
| Total current liabilities | $41.64B | $42.10B | $43.29B | $39.39B | $39.77B | $36.40B | $38.75B | $43.06B | $41.91B | $41.52B | $37.84B | $34.77B |
| Long-term debt | $62.48B | $64.53B | $58.94B | $62.97B | $62.96B | $64.53B | $60.34B | $58.51B | $58.05B | $63.80B | $52.19B | $55.63B |
| Other long-term liabilities | $36.88B | $2.33B | $34.96B | $34.13B | $34.59B | $33.77B | $32.71B | $35.78B | $35.15B | $35.50B | $34.28B | $33.69B |
| Total liabilities | $141.00B | $143.07B | $137.19B | $136.50B | $137.32B | $134.70B | $131.80B | $137.35B | $135.12B | $140.83B | $124.31B | $124.09B |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $18.0M | $18.0M | $18.0M | $18.0M | $18.0M | $18.0M | $18.0M | $18.0M | $18.0M | $18.0M | $20.20B | $20.04B |
| Retained earnings (deficit) | −$17.33B | −$17.87B | −$15.49B | −$14.23B | −$11.50B | −$9.53B | −$7.90B | −$4.96B | −$3.77B | −$2.38B | −$1.00B | $933.0M |
| Treasury stock | — | — | — | — | — | — | — | — | — | — | −$6.53B | −$6.53B |
| Accumulated other comprehensive income | −$1.16B | −$1.15B | −$1.14B | −$1.57B | −$1.54B | −$1.74B | −$1.93B | −$2.33B | −$2.51B | −$2.45B | −$2.31B | −$2.35B |
| Minority interest | $47.0M | $44.0M | $42.0M | $43.0M | $45.0M | — | — | — | — | — | $37.0M | $35.0M |
| Total shareholders' equity | −$5.93B | −$6.61B | −$3.23B | −$2.60B | −$138.0M | $1.46B | $3.36B | $6.07B | $6.82B | $8.05B | $10.40B | $12.13B |
| Key figures | ||||||||||||
| Total debt | $70.82B | $72.86B | $68.87B | $68.74B | $70.48B | $69.89B | $67.84B | $71.08B | $70.63B | $74.00B | $60.12B | $60.75B |
| Net cash (debt) | −$64.25B | −$63.47B | −$63.62B | −$63.07B | −$64.01B | −$64.71B | −$62.29B | −$63.79B | −$57.48B | −$55.93B | −$47.30B | −$47.46B |
| Working capital | −$7.97B | −$8.57B | −$14.23B | −$10.85B | −$10.51B | −$8.73B | −$13.17B | −$15.28B | −$8.10B | −$2.65B | −$4.84B | −$1.55B |
| Tangible book value | −$90.59B | −$93.06B | −$91.51B | −$92.54B | −$92.81B | −$92.31B | −$91.66B | −$95.87B | −$86.81B | −$87.60B | −$77.51B | −$78.56B |
| Book value per share | −$3.35 | −$3.73 | −$1.82 | −$1.47 | −$0.08 | $0.83 | $1.90 | $3.43 | $3.85 | $4.54 | $5.87 | $6.85 |
| Shares outstanding | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B | 1.77B |
| Current ratio | 0.81 | 0.80 | 0.67 | 0.72 | 0.74 | 0.76 | 0.66 | 0.65 | 0.81 | 0.94 | 0.87 | 0.96 |
| Quick ratio | 0.49 | 0.52 | 0.41 | 0.47 | 0.48 | 0.48 | 0.43 | 0.44 | 0.59 | 0.72 | 0.63 | 0.71 |
| Debt / equity | — | — | — | — | — | 47.80 | 20.17 | 11.71 | 10.36 | 9.20 | 5.78 | 5.01 |
| Equity / assets | −4.4% | −4.8% | −2.4% | −1.9% | −0.1% | 1.1% | 2.5% | 4.2% | 4.8% | 5.4% | 7.7% | 8.9% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed February 20, 2026); data from EODHD.
ABBV financial position
At the end of fiscal 2025 (December 31, 2025), AbbVie had total assets of $134.0 billion (down 0.9% from a year earlier), total liabilities of $137.2 billion and shareholders' equity of -$3.2 billion. It held $5.3 billion in cash and short-term investments against $69.1 billion of debt, net debt of $63.8 billion. Its current ratio was 0.67. In the latest quarter (ended June 30, 2026) total assets were $135.1 billion and equity -$5.9 billion.
Related: ABBV income statement, ABBV cash flow statement, ABBV key metrics. See the ABBV stock overview for the latest quote and news.
ABBV balance sheet FAQ
What are AbbVie's total assets?
AbbVie reported total assets of $134.0 billion at the end of fiscal 2025 (December 31, 2025), compared with $135.2 billion a year earlier.
How much debt does AbbVie have?
AbbVie had $69.1 billion of total debt at the end of fiscal 2025, including short-term borrowings. Its debt-to-equity ratio was —.
How much cash does AbbVie have?
AbbVie held $5.3 billion in cash and short-term investments at the end of fiscal 2025; with $69.1 billion of debt that is net debt of $63.8 billion.
What is AbbVie's book value?
AbbVie's shareholders' equity (book value) was -$3.2 billion at the end of fiscal 2025, or −$1.82 per share.
What is AbbVie's current ratio?
AbbVie had current assets of $29.1 billion and current liabilities of $43.3 billion, a current ratio of 0.67 (current liabilities exceed current assets).
How much goodwill does AbbVie have?
AbbVie carried $88.3 billion of goodwill and intangible assets, 65.9% of total assets, at the end of fiscal 2025.